Canada markets closed

Titan Pharmaceuticals, Inc. (TTNP)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
6.51+0.15 (+2.36%)
At close: 04:00PM EDT
Show:
Income Statement
Cash Flow
Annual

Balance Sheet

All numbers in thousands
Breakdown
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Assets
Current Assets
Cash
Cash And Cash Equivalents
6,760
2,937
6,037
5,413
-
Total Cash
6,760
2,937
6,037
5,413
-
Net Receivables
46
36
112
884
-
Inventory
0
106
293
328
-
Other Current Assets
199
314
480
522
-
Total Current Assets
8,018
3,603
7,229
7,328
-
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
774
2,000
2,114
3,307
-
Accumulated Depreciation
-706
-1,593
-1,397
-2,548
-
Net property, plant and equipment
68
407
717
759
-
Other long-term assets
-
48
48
-
-
Total non-current assets
68
455
765
759
-
Total Assets
8,086
4,058
7,994
8,087
-
Liabilities and stockholders' equity
Liabilities
Current Liabilities
Current Debt
500
-
-
327
-
Accounts Payable
348
695
795
1,253
-
Accrued liabilities
519
1,488
323
533
-
Deferred revenues
12
196
295
0
-
Other Current Liabilities
-
129
1,144
1,960
2,080
Total Current Liabilities
1,444
2,630
2,669
4,223
-
Non-current liabilities
Long Term Debt
-
-
-
332
4,019
Total non-current liabilities
0
65
187
332
-
Total Liabilities
1,444
2,695
2,856
4,555
-
Stockholders' Equity
Common Stock
2
1
10
7
-
Retained Earnings
-391,830
-386,261
-376,055
-367,279
-
Total stockholders' equity
6,642
1,363
5,138
3,532
-
Total liabilities and stockholders' equity
8,086
4,058
7,994
8,087
-